Clinical Pharmacology
Indications & Usage
rivaroxaban is listed as a TABLET formulation in the TABLET category. Consult official FDA labeling for full prescribing information.
Administration Context
rivaroxaban is administered via the ORAL route as a TABLET.
Administration Protocol
Prescribing Information
Refer to official FDA labeling or institutional protocols for complete dosage and administration instructions.
Safety Profile
Contraindications & Warnings
Consult the official FDA-approved labeling for complete contraindications, warnings, precautions, and patient-specific safety information.
National Drug Registry
Product and label metadata.
Marketing Category
ANDA
Route of Administration
ORAL
National Drug Code
71921-405
Manufacturer / Labeler
Florida Pharmaceutical Products, LLC
Dosage Form
TABLET
Strength
See labeling
Application Number
ANDA218445
SPL Identifier
f0ef9361-f06d-4028-97af-183b545f4aea
WHO Regulatory Intelligence
Vaccine Safety Information
Access evidence-based safety data and clinical guidelines from global health resources.